From ketamine FDA approval to personalized 3D-printed medicines.
PharmaTher took a ketamine product through FDA approval, which it sold in December 2025. That experience, from formulation to approval, is the foundation of what we do now. Mass manufacturing cannot provide personalized medicines. 3D printing can.
Today PharmaTher is a pharmaceutical 3D printing company. We print medicines on two delivery platforms: colon-targeted tablets, using the patent-pending pill-in-pill, and oral films. Our initial pipeline is peptides: BPC-157 and KPV. We hold exclusive North American distribution rights to Craft Health’s CraftMake™ pharmaceutical 3D printer.
Our partners.

Exclusive North American distributor
CraftMake™ systems, software, materials and service. Every placement seeds recurring revenue and runs M3DICINES™ formulations.

Center of Excellence
PD Labs: a U.S. national 503A compounding pharmacy with 26+ years of experience, for dispensing and R&D. Our peptide products are made here.
GMP contract manufacturer
FDA-track products and CDMO services, including clinical trial supply.
Management and Partners

25+ years in specialty life sciences and investing; founder of PharmaTher and Revive Therapeutics.
LinkedIn ↗
Public-company finance and administration; principal of Marrelli Support Services since 2009.
LinkedIn ↗
Clinical pharmacist for 35 years and certified clinical nutritionist; PD Labs is PharmaTher's U.S. 503A Center of Excellence.
LinkedIn ↗
Pharmacist; co-founder of Craft Health, maker of CraftMake™. PhD and MBA, National University of Singapore.
Craft Health ↗
Pharmacist; co-founder of Craft Health. PhD in pharmacy (NUS) focused on 3D-printed personalized dosage forms.
Craft Health ↗Board of directors

30+ years in pharma and drug delivery; former EVP R&D at Ironshore Pharmaceuticals.
LinkedIn ↗Investor across biotech, technology and real estate; President at Sanscon.
